Cell-type specific targeting and gene expression using a variant of polyoma VP1 virus-like particles

Biological Chemistry

Volumn 384, Issue 2, 2003, Pages 247-255

  Gleiter, Stefan ^a   Lilie, Hauke ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

ErbB2 receptor; Gene transfer; Polyomavirus; Targetting; VP1; VP1 Z

Indexed keywords

BETA GALACTOSIDASE; CHLOROQUINE; GREEN FLUORESCENT PROTEIN; MONOCLONAL ANTIBODY; PLASMID DNA; PROTEIN VP1; TRASTUZUMAB; TYROSINE KINASE RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL SPECIFICITY; CELL TYPE; COMPLEX FORMATION; CONTROLLED STUDY; ENDOCYTOSIS; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC CODE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; NONHUMAN; PLASMID; POLYOMA VIRUS; PRIORITY JOURNAL; REPORTER GENE; VIRUS PARTICLE;

ANTIBODIES, MONOCLONAL; BETA-GALACTOSIDASE; BREAST NEOPLASMS; CAPSID PROTEINS; CELL LINE; CHLOROQUINE; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; HUMANS; LUMINESCENT PROTEINS; MICROSCOPY, FLUORESCENCE; PLASMIDS; POLYOMAVIRUS; RECEPTOR, ERBB-2; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; VARIATION (GENETICS);

POLYOMAVIRUS;

EID: 0037298835     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2003.028     Document Type: Article

References (45)

1. Bauer, P.H., Cui, C., Liu, R., Stehle, T., Harrison, S.C., DeCaprio, J.A., and Benjamin, T.L. (1999). Discrimination between sialic acid-containing receptors and pseudoreceptors regulates polyomavirus spread in the mouse. J. Virol. 73, 5826-5832.
2. Chu, T.H. and Dornburg, R. (1997). Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies. J. Virol. 71, 720-725.
3. Chu, T.H., Martinez, I., Sheay, W.C., and Dornburg, R. (1994). Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins. Gene Ther. 1, 292-299.
4. Clynes, R.A., Towers, T.L., Presta, L.G., and Ravetch, J.V. (2000). Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nature Med. 6, 443-446.
5. Cuello, M., Ettenberg, S.A., Clark, A.S., Keane, M.M., Posner, R.H., Nau, M.M., Dennis, P.A., and Lipkowitz, S. (2001). Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand- mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. Cancer Res. 61, 4892-4900.
6. Eckhart, W. (1990). Polyomavirinae and their replication. In: Fundamental Virology, B.N. Fields and D. M. Knipe, eds. (Raven Press), pp. 727-742.
7. Fendly, B.M., Winget, M., Hudziak, R.M., Lipari, M.T., Napier, M.A., and Ullrich, A. (1990). Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. Cancer Res. 50, 1550-1558.
8. Forstova, J., Krauzewicz, N., Sandig, V., Elliott, J., Palkova, Z., Strauss, M., and Griffin, B.E. (1995). Polyoma virus pseudocapsids as efficient carriers of heterologous DNA into mammalian cells. Hum. Gene Ther. 6, 297-306.
9. Foster, B.J. and Kern, J.A. (1997). HER2-targeted gene transfer. Hum. Gene Ther. 8, 719-727.
10. Gedvilaite, A., Frommel, C., Sasnauskas, K., Micheel, B., Ozel, M., Behrsing, O., Staniulis, J., Jandrig, B., Scherneck, S., and Ulrich, R. (2000). Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein. Virology 273, 21-35.
11. Gleiter, S. and Lilie, H. (2001). Coupling of antibodies via protein Z on modified polyoma virus-like particles. Protein Sci. 10, 434-444.
12. Gleiter, S., Stubenrauch, K., and Lilie, H. (1999). Changing the surface of a virus shell: fusion of an enzyme to polyoma VP1. Protein Sci. 8, 2562-2569.
13. Henke, S., Rohmann, A., Bertling, W.M., Dingermann, T., and Zimmer, A. (2000). Enhanced in vitro oligonucleotide and plasmid DNA transport by VP1 virus-like particles. Pharm. Res. 17, 1062-1070.
14. Herrmann, M., der Lieth, C.W., Stehling, P., Reutter, W., and Pawlita, M. (1997). Consequences of a subtle sialic acid modification on the murine polyomavirus receptor. J. Virol. 71, 5922-5931.
15. Jiang, A., Chu, T.H., Nocken, F., Cichutek, K., and Dornburg, R. (1998). Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies. J. Virol. 72, 10148-10156.
16. Kirpotin, D., Park, J.W., Hong, K., Zalipsky, S., Li, W.L., Carter, P., Benz, C.C., and Papahadjopoulos, D. (1997). Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Biochemistry 36, 66-75.
17. Klapper, L.N., Waterman, H., Sela, M., and Yarden,Y. (2000). Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2. Cancer Res. 60, 3384-3388.
18. Krauzewicz, N., Cox, C., Soeda, E., Clark, B., Rayner, S., and Griffin, B.E. (2000a). Sustained ex vivo and in vivo transfer of a reporter gene using polyoma virus pseudocapsids. Gene Ther. 7, 1094-1102.
19. Krauzewicz, N., Stokrova, J., Jenkins, C., Elliott, M., Higgins, C.F., and Griffin, B.E. (2000b). Virus-like gene transfer into cells mediated by polyoma virus pseudocapsids. Gene Ther. 7, 2122-2131.
20. Langner, J., Zentgraf, H., and Pawlita, M. (1998).Viral particles with heterologous binding motifs. An approach to specifically alter the tropism of the B-lymphotropic papovavirus. Adv. Exp. Med. Biol. 451, 415-422.
21. Leavitt, A.D., Roberts, T.M., and Garcea, R.L. (1985). Polyoma virus major capsid protein, VP1. Purification after high level expression in Escherichia coli. J. Biol. Chem. 260, 12803-12809.
22. Martin, F., Kupsch, J., Takeuchi, Y., Russell, S., Cosset, F.L., and Collins, M. (1998). Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope. Hum. Gene Ther. 9, 737-746.
23. Moreland, R.B. and Garcea, R.L. (1991). Characterization of a nuclear localization sequence in the polyomavirus capsid protein VP1. Virology 185, 513-518.
24. Moreland, R.B., Montross, L., and Garcea, R.L. (1991). Characterization of the DNA-binding properties of the polyomavirus capsid protein VP1. J. Virol. 65, 1168-1176.
25. Morizono, K., Bristol, G., Xie, Y., Kung, S.K., and Chen, I.S. (2001). Antibody-directed targeting of retroviral vectors via cell surface antigens. J. Virol. 75, 8016-8020.
26. Ohno, K. and Meruelo, D. (1997). Retrovirus vectors displaying the IgG-binding domain of protein A. Biochem. Mol. Med 62, 123-127.
27. Ohno, K., Sawai, K., Iijima, Y., Levin, B., and Meruelo, D. (1997). Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nature Biotechnol. 15, 763-767.
28. Park, B.W., Zhang, H.T., Wu, C., Berezov, A., Zhang, X., Dua, R., Wang, Q., Kao, G., O'Rourke, D.M., Greene, M.I., and Murali, R. (2000). Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo. Nature Biotechnol. 18, 194-198.
29. Park, J.W., Hong, K., Carter, P., Asgari, H., Guo, L.Y., Keller, G.A., Wirth, C., Shalaby, R., Kotts, C., Wood, W.I., and. (1995). Development of anti-p185HER2 immunoliposomes for cancer therapy. Proc. Natl Acad. Sci. USA 92, 1327-1331.
30. Richterova, Z., Liebl, D., Horak, M., Palkova, Z., Stokrova, J., Hozak, P., Korb, J., and Forstova,J. (2001). Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei. J. Virol. 75, 10880-10891.
31. Salunke, D.M., Caspar, D.L., and Garcea, R.L. (1986). Self-assembly of purified polyomavirus capsid protein VP1. Cell 46, 895-904.
32. Salunke, D.M., Caspar, D.L., and Garcea, R.L. (1989). Polymorphism in the assembly of polyomavirus capsid protein VP1. Biophys. J. 56, 887-900.
33. Schmidt, M., Hynes, N.E., Groner, B., and Wels, W. (1996). A bivalent single-chain antibody-toxin specific for ErbB-2 and the EGF receptor. Int. J. Cancer 65, 538-546.
34. Schmidt, U., Gunther, C., Rudolph, R., and Bohm, G. (2001). Protein and peptide delivery via engineered polyomavirus-like particles. FASEB J. 15, 1646-1648.
35. Slamon, D.J., Godolphin,W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Stuart, S.G., Udove,J., Ullrich, A. et al. (1989). Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707-712.
36. Sliwkowski, M.X., Lofgren, J.A., Lewis, G.D., Hotaling, T.E., Fendly, B.M., and Fox, J.A. (1999). Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin). Semin. Oncol. 26, 60-70.
37. Soeda, E., Krauzewicz, N., Cox, C., Stokrova, J., Forstova, J., and Griffin, B.E. (1998). Enhancement by polylysine of transient, but not stable, expression of genes carried into cells by polyoma VP1 pseudocapsids. Gene Ther. 5, 1410-1419.
38. Stehle, T. and Harrison, S.C. (1996). Crystal structures of murine polyomavirus in complex with straight- chain and branched-chain sialyloligosaccharide receptor fragments. Structure 4, 183-194.
39. Stehle, T. and Harrison, S.C. (1997). High-resolution structure of a polyomavirus VP1-oligosaccharide complex: implications for assembly and receptor binding. EMBO J. 16, 5139-5148.
40. Stehle, T., Yan, Y., Benjamin, T.L., and Harrison, S.C. (1994). Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 369, 160-163.
41. Stokrova, J., Palkova, Z., Fischer, L., Richterova, Z., Korb, J., Griffin, B.E., and Forstova, J. (1999). Interactions of heterologous DNA with polyomavirus major structural protein, VP1. FEBS Lett. 445, 119-125.
42. Stubenrauch, K., Bachmann, A., Rudolph, R., and Lilie, H. (2000). Purification of a viral coat protein by an engineered polyionic sequence. J. Chromatogr. B Biomed. Sci. Appl. 737, 77-84.
43. Stubenrauch, K., Gleiter, S., Brinkmann, U., Rudolph, R., and Lilie, H. (2001). Conjugation of an antibody Fv fragment to a virus coat protein: cell-specific targeting of recombinant polyoma virus-like particles. Biochem J. 356, 867-873.
44. Yang, Y.W. and Chen, L.H. (2000). Gene delivery via polyomavirus major capsid protein VP(1), isolated from recombinant Escherichia coli. Biotechnol. Appl. Biochem. 32, 73-79.
45. Yerushalmi, N., Brinkmann, U., Brinkmann, E., Pai, L., and Pastan, I. (2000). Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomes. Cancer Gene Ther. 7, 91-96.